Terms: = Ovarian cancer AND BCL2, Bcl-2, 596, ENSG00000171791 AND Clinical Outcome
15 results:
1. Prohibitin 1 interacts with p53 in the regulation of mitochondrial dynamics and chemoresistance in gynecologic cancers.
Kong B; Han CY; Kim SI; Patten DA; Han Y; Carmona E; Shieh DB; Cheung AC; Mes-Masson AM; Harper ME; Song YS; Tsang BK
J Ovarian Res; 2022 Jun; 15(1):70. PubMed ID: 35668443
[TBL] [Abstract] [Full Text] [Related]
2. Hsa-miR-105-1 Regulates Cisplatin-Resistance in ovarian Carcinoma Cells by Targeting ANXA9.
Kou X; Ding H; Li L; Chao H
Anal Cell Pathol (Amst); 2021; 2021():6662486. PubMed ID: 33680718
[TBL] [Abstract] [Full Text] [Related]
3. The BAX/BAK-like protein BOK is a prognostic marker in colorectal cancer.
Carberry S; D'Orsi B; Monsefi N; Salvucci M; Bacon O; Fay J; Rehm M; McNamara D; Kay EW; Prehn JHM
Cell Death Dis; 2018 Jan; 9(2):125. PubMed ID: 29374142
[TBL] [Abstract] [Full Text] [Related]
4. Molecular correlates of platinum response in human high-grade serous ovarian cancer patient-derived xenografts.
Topp MD; Hartley L; Cook M; Heong V; Boehm E; McShane L; Pyman J; McNally O; Ananda S; Harrell M; Etemadmoghadam D; Galletta L; Alsop K; Mitchell G; Fox SB; Kerr JB; Hutt KJ; Kaufmann SH; Australian Ovarian Cancer Study ; Swisher EM; Bowtell DD; Wakefield MJ; Scott CL
Mol Oncol; 2014 May; 8(3):656-68. PubMed ID: 24560445
[TBL] [Abstract] [Full Text] [Related]
5. BAD phosphorylation determines ovarian cancer chemosensitivity and patient survival.
Marchion DC; Cottrill HM; Xiong Y; Chen N; Bicaku E; Fulp WJ; Bansal N; Chon HS; Stickles XB; Kamath SG; Hakam A; Li L; Su D; Moreno C; Judson PL; Berchuck A; Wenham RM; Apte SM; Gonzalez-Bosquet J; Bloom GC; Eschrich SA; Sebti S; Chen DT; Lancaster JM
Clin Cancer Res; 2011 Oct; 17(19):6356-66. PubMed ID: 21849418
[TBL] [Abstract] [Full Text] [Related]
6. Fertility-sparing surgery in young women with mucinous adenocarcinoma of the ovary.
Kajiyama H; Shibata K; Mizuno M; Nawa A; Mizuno K; Matsuzawa K; Kawai M; Hosono S; Nagasaka T; Kikkawa F
Gynecol Oncol; 2011 Aug; 122(2):334-8. PubMed ID: 21575985
[TBL] [Abstract] [Full Text] [Related]
7. Prognostic significance of CD3+ tumor-infiltrating lymphocytes in ovarian carcinoma.
Tomsová M; Melichar B; Sedláková I; Steiner I
Gynecol Oncol; 2008 Feb; 108(2):415-20. PubMed ID: 18037158
[TBL] [Abstract] [Full Text] [Related]
8. HER-2/neu and bcl-2 in ovarian carcinoma: clinicopathologic, immunohistochemical, and molecular study in patients with shorter and longer survival.
Raspollini MR; Amunni G; Villanucci A; Castiglione F; Rossi Degl'Innocenti D; Baroni G; Paglierani M; Taddei GL
Appl Immunohistochem Mol Morphol; 2006 Jun; 14(2):181-6. PubMed ID: 16785787
[TBL] [Abstract] [Full Text] [Related]
9. Multidrug resistance-related phenotype and apoptosis-related protein expression in ovarian serous carcinomas.
Yakirevich E; Sabo E; Naroditsky I; Sova Y; Lavie O; Resnick MB
Gynecol Oncol; 2006 Jan; 100(1):152-9. PubMed ID: 16198399
[TBL] [Abstract] [Full Text] [Related]
10. [bcl-2 in ovarian carcinoma: a clinicopathologic, immunohistochemical and molecular study].
Raspollini MR; Castiglione F; Rossi Degl'Innocenti D; Baroni G; Amunni G; Villanucci A; Taddei GL
Pathologica; 2004 Dec; 96(6):465-9. PubMed ID: 15792372
[TBL] [Abstract] [Full Text] [Related]
11. Expression of Bcl-xL in ovarian carcinoma is associated with chemoresistance and recurrent disease.
Williams J; Lucas PC; Griffith KA; Choi M; Fogoros S; Hu YY; Liu JR
Gynecol Oncol; 2005 Feb; 96(2):287-95. PubMed ID: 15661210
[TBL] [Abstract] [Full Text] [Related]
12. Microinvasive squamous cell carcinoma of the cervix: immunohistochemically detected prognostic factors in a case with poor clinical outcome.
Kohlberger P; Edwards L; Hacker NF
Gynecol Oncol; 2003 Aug; 90(2):443-5. PubMed ID: 12893215
[TBL] [Abstract] [Full Text] [Related]
13. Expression of bcl-2 family member Bid in normal and malignant tissues.
Krajewska M; Zapata JM; Meinhold-Heerlein I; Hedayat H; Monks A; Bettendorf H; Shabaik A; Bubendorf L; Kallioniemi OP; Kim H; Reifenberger G; Reed JC; Krajewski S
Neoplasia; 2002; 4(2):129-40. PubMed ID: 11896568
[TBL] [Abstract] [Full Text] [Related]
14. Reduced expression of BAX is associated with poor prognosis in patients with epithelial ovarian cancer: a multifactorial analysis of TP53, p21, BAX and bcl-2.
Schuyer M; van der Burg ME; Henzen-Logmans SC; Fieret JH; Klijn JG; Look MP; Foekens JA; Stoter G; Berns EM
Br J Cancer; 2001 Nov; 85(9):1359-67. PubMed ID: 11720475
[TBL] [Abstract] [Full Text] [Related]
15. Differential expression of apoptosis associated genes bax and bcl-2 in ovarian cancer.
Marx D; Binder C; Meden H; Lenthe T; Ziemek T; Hiddemann T; Kuhn W; Schauer A
Anticancer Res; 1997; 17(3C):2233-40. PubMed ID: 9216694
[TBL] [Abstract] [Full Text] [Related]
